06/03/2026
What if the most promising new tool against opioid relapse turned out to be a drug your pharmacy has carried for decades?
A 2026 University of Iowa study showed that acetazolamide, an old glaucoma medication, reverses the synaptic rewiring in the reward center that current addiction medications do not touch. A single dose was enough to reduce drug-seeking in animal models after long abstinence.
Dr. Drew Edwards breaks down what the finding means for people in recovery and the families supporting them: https://neurogenesisproject.com/blog/acetazolamide-opioid-relapse-brain-rewiring
If you or someone you love has been told that staying clean is just a matter of motivation, what would it change if you knew the science says otherwise?